Fate Therapeutics Inc (FATE)
4.54
-0.24
(-5.02%)
USD |
NASDAQ |
Apr 23, 16:00
4.535
0.00 (0.00%)
Pre-Market: 20:00
Fate Therapeutics Total Liabilities (Quarterly): 137.80M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 137.80M |
| September 30, 2023 | 141.01M |
| June 30, 2023 | 147.00M |
| March 31, 2023 | 152.86M |
| December 31, 2022 | 221.62M |
| September 30, 2022 | 231.35M |
| June 30, 2022 | 226.58M |
| March 31, 2022 | 224.99M |
| December 31, 2021 | 242.62M |
| September 30, 2021 | 254.24M |
| June 30, 2021 | 263.60M |
| March 31, 2021 | 255.87M |
| December 31, 2020 | 238.01M |
| September 30, 2020 | 202.08M |
| June 30, 2020 | 179.48M |
| March 31, 2020 | 102.67M |
| December 31, 2019 | 57.52M |
| September 30, 2019 | 72.16M |
| June 30, 2019 | 72.35M |
| March 31, 2019 | 75.03M |
| December 31, 2018 | 52.56M |
| September 30, 2018 | 46.02M |
| Date | Value |
|---|---|
| June 30, 2018 | 31.33M |
| March 31, 2018 | 28.42M |
| December 31, 2017 | 28.10M |
| September 30, 2017 | 26.93M |
| June 30, 2017 | 18.74M |
| March 31, 2017 | 21.47M |
| December 31, 2016 | 21.89M |
| September 30, 2016 | 23.92M |
| June 30, 2016 | 26.05M |
| March 31, 2016 | 27.98M |
| December 31, 2015 | 29.92M |
| September 30, 2015 | 31.41M |
| June 30, 2015 | 32.41M |
| March 31, 2015 | 23.24M |
| December 31, 2014 | 22.84M |
| September 30, 2014 | 13.43M |
| June 30, 2014 | 3.913M |
| March 31, 2014 | 4.472M |
| December 31, 2013 | 4.735M |
| September 30, 2013 | 89.44M |
| June 30, 2013 | 6.323M |
| December 31, 2012 | 63.90M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
57.52M
Minimum
Dec 2019
263.60M
Maximum
Jun 2021
180.20M
Average
202.08M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 617.71M |
| Regeneron Pharmaceuticals Inc | 7.107B |
| Sarepta Therapeutics Inc | 2.405B |
| ADMA Biologics Inc | 193.98M |
| Ocular Therapeutix Inc | 160.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 506.22M |
| Shareholders Equity (Quarterly) | 368.42M |
| Current Ratio | 8.481 |